Last reviewed · How we verify

EndoSequence

University of the Pacific · FDA-approved active Small molecule

EndoSequence is a bioresorbable endodontic sealer that sets through a hydration reaction to create a biocompatible root canal filling material.

EndoSequence is a bioresorbable endodontic sealer that sets through a hydration reaction to create a biocompatible root canal filling material. Used for Root canal obturation and sealing in endodontic therapy.

At a glance

Generic nameEndoSequence
Also known asEndoSequence®
SponsorUniversity of the Pacific
ModalitySmall molecule
Therapeutic areaDentistry/Endodontics
PhaseFDA-approved

Mechanism of action

EndoSequence is a calcium silicate-based root canal sealer designed for endodontic therapy. It sets via a hydration reaction rather than a setting reaction dependent on moisture, allowing it to harden in the presence of moisture. The material is bioresorbable and promotes periapical healing through its bioactive properties.

Approved indications

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results